{"id":5973,"date":"2025-03-05T16:37:00","date_gmt":"2025-03-05T22:37:00","guid":{"rendered":"https:\/\/nanostherapeutics.com\/?p=5973"},"modified":"2025-09-22T16:39:43","modified_gmt":"2025-09-22T21:39:43","slug":"pharma-executive-and-gene-therapy-access-expert-ramesh-arjunji-phd-joins-nanoscope-as-executive-vice-president-value-and-access","status":"publish","type":"post","link":"https:\/\/nanostherapeutics.com\/ja\/2025\/03\/05\/pharma-executive-and-gene-therapy-access-expert-ramesh-arjunji-phd-joins-nanoscope-as-executive-vice-president-value-and-access\/","title":{"rendered":"\u88fd\u85ac\u4f1a\u793e\u306e\u5e79\u90e8\u3067\u907a\u4f1d\u5b50\u6cbb\u7642\u30a2\u30af\u30bb\u30b9\u306e\u5c02\u9580\u5bb6\u3067\u3042\u308b\u30e9\u30e1\u30b7\u30e5\u30fb\u30a2\u30eb\u30b8\u30e5\u30f3\u30b8\u535a\u58eb\u304c\u3001\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u306e\u4fa1\u5024\u3068\u30a2\u30af\u30bb\u30b9\u62c5\u5f53\u30a8\u30b0\u30bc\u30af\u30c6\u30a3\u30d6\u30d0\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u3068\u3057\u3066\u5165\u793e"},"content":{"rendered":"<div class=\"col-sm-8 col-vcenter col-xs-12\">\n<div class=\"col-sm-8 col-vcenter col-xs-12\">\n<div class=\"col-sm-8 col-vcenter col-xs-12\">\n<div class=\"col-sm-8 col-vcenter col-xs-12\">\n<div class=\"col-sm-8 col-vcenter col-xs-12\">\n<h1><\/h1>\n<\/div>\n<div class=\"col-sm-4 col-xs-12 col-vcenter\">\n<div class=\"image logo logo-wrapper\" data-src=\"https:\/\/mma.prnewswire.com\/media\/1333752\/Nanoscope_Therapeutics_Logo.jpg?p=publish\" data-asset-type=\"photo\" data-asset-label=\"Logo\" data-download-url=\"https:\/\/mma.prnewswire.com\/media\/1333752\/Nanoscope_Therapeutics_Logo.jpg\" data-tweet-text=\"Nanoscope Therapeutics Logo (PRNewsfoto\/Nanoscope Therapeutics)\" data-pinterest-text=\"Nanoscope Therapeutics Logo (PRNewsfoto\/Nanoscope Therapeutics)\" data-linkedin-text=\"Nanoscope Therapeutics Logo (PRNewsfoto\/Nanoscope Therapeutics)\" data-facebook-share-text=\"Nanoscope Therapeutics Logo (PRNewsfoto\/Nanoscope Therapeutics)\" data-twitter-share-url=\"https:\/\/mma.prnewswire.com\/media\/1333752\/Nanoscope_Therapeutics_Logo.jpg?p=twitter\" data-facebook-share-url=\"https:\/\/mma.prnewswire.com\/media\/1333752\/Nanoscope_Therapeutics_Logo.jpg?p=facebook\" data-pinterest-share-url=\"https:\/\/mma.prnewswire.com\/media\/1333752\/Nanoscope_Therapeutics_Logo.jpg?p=publish\" data-linkedin-share-url=\"https:\/\/mma.prnewswire.com\/media\/1333752\/Nanoscope_Therapeutics_Logo.jpg?p=linkedin\">\n<p><span class=\"legendSpanClass\"><span class=\"xn-location\">\u30c0\u30e9\u30b9<\/span><\/span>,\u00a0<span class=\"legendSpanClass\"><span class=\"xn-chron\">2025\u5e743\u67085\u65e5<\/span><\/span> \u2014\u00a0<a href=\"http:\/\/nanostherapeutics.com\/ja\/\" target=\"_blank\" rel=\"nofollow noopener\">\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u682a\u5f0f\u4f1a\u793e<\/a>\u907a\u4f1d\u6027\u7db2\u819c\u75be\u60a3\u304a\u3088\u3073\u52a0\u9f62\u9ec4\u6591\u5909\u6027\u75c7\uff08AMD\uff09\u306e\u907a\u4f1d\u5b50\u6cbb\u7642\u3092\u958b\u767a\u3057\u3066\u3044\u308b\u5f8c\u671f\u81e8\u5e8a\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u3067\u3042\u308b\u306f\u3001\u672c\u65e5\u3001\u00a0<span class=\"xn-person\">\u30e9\u30e1\u30b7\u30e5\u30fb\u30a2\u30eb\u30b8\u30e5\u30f3\u30b8<\/span>, \u535a\u58eb\u53f7\u3092\u6301\u3064\u30a2\u30eb\u30b8\u30e5\u30f3\u30b8\u6c0f\u304c\u3001\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u793e\u306b\u30d0\u30ea\u30e5\u30fc\uff06\u30a2\u30af\u30bb\u30b9\u62c5\u5f53\u30a8\u30b0\u30bc\u30af\u30c6\u30a3\u30d6\u30d0\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u3068\u3057\u3066\u5165\u793e\u3057\u307e\u3057\u305f\u3002\u30a2\u30eb\u30b8\u30e5\u30f3\u30b8\u6c0f\u306f\u3001\u30d0\u30a4\u30aa\u533b\u85ac\u54c1\u696d\u754c\u306b\u304a\u3051\u308b\u69d8\u3005\u306a\u30ea\u30fc\u30c0\u30fc\u30b7\u30c3\u30d7\u8077\u3067\u57f9\u3063\u305f\u3001\u5546\u696d\u5316\u3001\u7814\u7a76\u958b\u767a\u3001\u30e1\u30c7\u30a3\u30ab\u30eb\u30a2\u30d5\u30a7\u30a2\u30fc\u30ba\u3001\u4e8b\u696d\u958b\u767a\u306a\u3069\u5e45\u5e83\u3044\u7d4c\u9a13\u3092\u6709\u3057\u3066\u3044\u307e\u3059\u3002.<\/p>\n<p>\u201c\u300c\u30e9\u30e1\u30b7\u30e5\u6c0f\u306f\u3001\u773c\u79d1\u3001\u795e\u7d4c\u79d1\u3001\u816b\u760d\u5b66\u3001\u514d\u75ab\u5b66\u3001\u533b\u7642\u6a5f\u5668\u306a\u3069\u3001\u5e45\u5e83\u3044\u696d\u754c\u7d4c\u9a13\u306b\u52a0\u3048\u3001\u6700\u3082\u5546\u696d\u5316\u306b\u6210\u529f\u3057\u305f\u907a\u4f1d\u5b50\u6cbb\u7642\u85ac\u306e\u3044\u304f\u3064\u304b\u306b\u304a\u3044\u3066\u3001\u91cd\u8981\u306a\u5e02\u5834\u30a2\u30af\u30bb\u30b9\u30ea\u30fc\u30c0\u30fc\u3068\u3057\u3066\u306e\u5f79\u5272\u3092\u679c\u305f\u3057\u3066\u304d\u307e\u3057\u305f\u3002\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\u60a3\u8005\u306b\u5bfe\u3059\u308b\u521d\u306e\u518d\u751f\u6cbb\u7642\u85ac\u3068\u3057\u3066MCO-010\u3092\u767a\u58f2\u3059\u308b\u6e96\u5099\u3092\u9032\u3081\u308b\u306b\u3042\u305f\u308a\u3001\u5f7c\u306e\u8ca2\u732e\u3092\u671f\u5f85\u3057\u3066\u3044\u307e\u3059\u300d\u3068\u8ff0\u3079\u305f\u3002\u00a0<span class=\"xn-person\">\u30b9\u30e9\u30cb\u30e3\u30fb\u30d0\u30bf\u30c1\u30e3\u30ea\u30e4<\/span>\u3001Nanoscope \u306e\u5171\u540c\u5275\u8a2d\u8005\u517c CEO\u3002<\/p>\n<p>\u201c\u300c\u79c1\u306f\u3053\u308c\u307e\u3067\u3001\u6570\u3005\u306e\u907a\u4f1d\u5b50\u6cbb\u7642\u85ac\u3092\u5e02\u5834\u306b\u9001\u308a\u51fa\u3057\u3001\u5fc5\u8981\u3068\u3059\u308b\u3067\u304d\u308b\u3060\u3051\u591a\u304f\u306e\u60a3\u8005\u3055\u3093\u306b\u5c4a\u3051\u308b\u3068\u3044\u3046\u8cb4\u91cd\u306a\u7d4c\u9a13\u3092\u7a4d\u3093\u3067\u304d\u307e\u3057\u305f\u3002\u79c1\u306e\u5c02\u9580\u77e5\u8b58\u3092\u6d3b\u304b\u3057\u3001\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u793e\u304c\u540c\u69d8\u306e\u6210\u529f\u3092\u53ce\u3081\u3001\u4eba\u751f\u3092\u5909\u3048\u308b\u3088\u3046\u306a\u6cbb\u7642\u6cd5\u3092\u6700\u3082\u5fc5\u8981\u3068\u3059\u308b\u4eba\u3005\u306b\u5c4a\u3051\u3089\u308c\u308b\u3088\u3046\u8ca2\u732e\u3067\u304d\u308b\u3053\u3068\u3092\u5927\u5909\u5b09\u3057\u304f\u601d\u3044\u307e\u3059\u300d\u3068\u30a2\u30eb\u30b8\u30e5\u30f3\u30b8\u535a\u58eb\u306f\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002.<\/p>\n<p>\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u306b\u5165\u793e\u3059\u308b\u524d\u3001\u30a2\u30eb\u30b8\u30e5\u30f3\u30b8\u535a\u58eb\u306f\u30af\u30ea\u30b9\u30bf\u30eb\u30d0\u30a4\u30aa\u30c6\u30c3\u30af\u3067\u30b0\u30ed\u30fc\u30d0\u30eb\u30d0\u30ea\u30e5\u30fc\uff06\u30a2\u30af\u30bb\u30b9\u62c5\u5f53\u30b7\u30cb\u30a2\u30d0\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u3092\u52d9\u3081\u3066\u3044\u307e\u3057\u305f\u3002\u30af\u30ea\u30b9\u30bf\u30eb\u30d0\u30a4\u30aa\u30c6\u30c3\u30af\u4ee5\u524d\u306f\u3001SSI\u30b9\u30c8\u30e9\u30c6\u30b8\u30fc\u3067\u30a8\u30d3\u30c7\u30f3\u30b9\u30b7\u30f3\u30bb\u30b7\u30b9\u62c5\u5f53\u30d0\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u517c\u8cac\u4efb\u8005\u3068\u3057\u3066\u3001\u30af\u30e9\u30a4\u30a2\u30f3\u30c8\u306b\u30a8\u30d3\u30c7\u30f3\u30b9\u751f\u6210\u6226\u7565\u306b\u3064\u3044\u3066\u30a2\u30c9\u30d0\u30a4\u30b9\u3092\u884c\u3063\u3066\u3044\u307e\u3057\u305f\u3002SSI\u30b9\u30c8\u30e9\u30c6\u30b8\u30fc\u4ee5\u524d\u306f\u3001\u30a2\u30f4\u30ed\u30d3\u30aa\u3067\u30d0\u30ea\u30e5\u30fc\uff06\u30a2\u30af\u30bb\u30b9\u62c5\u5f53\u30d0\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u3068\u3057\u3066\u3001\u30e9\u30a4\u30bd\u30bd\u30fc\u30e0\u84c4\u7a4d\u75c7\u907a\u4f1d\u5b50\u6cbb\u7642\u88fd\u54c1\u306e\u30a8\u30d3\u30c7\u30f3\u30b9\u751f\u6210\u6226\u7565\u306e\u958b\u767a\u3068\u5b9f\u884c\u3092\u4e3b\u5c0e\u3057\u3066\u3044\u307e\u3057\u305f\u3002\u30a2\u30f4\u30ed\u30d3\u30aa\u4ee5\u524d\u306f\u3001\u30a2\u30f4\u30a7\u30af\u30b7\u30b9\/\u30ce\u30d0\u30eb\u30c6\u30a3\u30b9\u907a\u4f1d\u5b50\u6cbb\u7642\u90e8\u9580\u3067\u3001\u810a\u9ac4\u6027\u7b4b\u840e\u7e2e\u75c7\u306e\u907a\u4f1d\u5b50\u6cbb\u7642\u85ac\u30be\u30eb\u30b2\u30f3\u30b9\u30de\u306e\u30b0\u30ed\u30fc\u30d0\u30ebHTA\u30a8\u30f3\u30b2\u30fc\u30b8\u30e1\u30f3\u30c8\u306e\u6226\u7565\u3068\u5b9f\u884c\u3092\u4e3b\u5c0e\u3057\u3066\u3044\u307e\u3057\u305f\u3002\u30a2\u30eb\u30b8\u30e5\u30f3\u30b8\u535a\u58eb\u306f\u3001GSK\u3001\u30a2\u30eb\u30b3\u30f3\u3001BMS\u3001\u30d0\u30a4\u30aa\u30b8\u30a7\u30f3\u3001\u30d5\u30a1\u30a4\u30b6\u30fc\u3001\u30a8\u30f3\u30c9\u30d5\u30a1\u30fc\u30de\u30b7\u30e5\u30fc\u30c6\u30a3\u30ab\u30eb\u30ba\u3001\u30bb\u30f3\u30c8\u30b3\u30a2\/\u30b8\u30e7\u30f3\u30bd\u30f3\u30fb\u30a8\u30f3\u30c9\u30fb\u30b8\u30e7\u30f3\u30bd\u30f3\u3067\u3082\u6307\u5c0e\u7684\u7acb\u5834\u3092\u6b74\u4efb\u3057\u3066\u3044\u307e\u3059\u3002\u7d4c\u55b6\u79d1\u5b66\u3001\u30de\u30fc\u30b1\u30c6\u30a3\u30f3\u30b0\u3001\u7d71\u8a08\u5b66\u306e\u535a\u58eb\u53f7\u3092\u53d6\u5f97\u3057\u3066\u3044\u307e\u3059\u3002\u00a0<span class=\"xn-org\">\u30c6\u30ad\u30b5\u30b9\u5927\u5b66<\/span>\u6a5f\u68b0\u5de5\u5b66\u4fee\u58eb\u53f7\u53d6\u5f97\u00a0<span class=\"xn-org\">\u30d5\u30ed\u30ea\u30c0\u5dde\u7acb\u5927\u5b66<\/span>\u3001\u822a\u7a7a\u5de5\u5b66\u306e\u5b66\u58eb\u53f7\u3092\u53d6\u5f97\u00a0<span class=\"xn-org\">\u30a4\u30f3\u30c9\u5de5\u79d1\u5927\u5b66<\/span>.<\/p>\n<p><b>\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u306b\u3064\u3044\u3066<br class=\"dnr\" \/><\/b>\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u306f\u3001\u73fe\u5728\u6cbb\u7642\u6cd5\u304c\u5b58\u5728\u3057\u306a\u3044\u7db2\u819c\u5909\u6027\u75be\u60a3\u306b\u3088\u308a\u5931\u660e\u3057\u305f\u4f55\u767e\u4e07\u4eba\u3082\u306e\u60a3\u8005\u306e\u305f\u3081\u306b\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u30aa\u30d7\u30c8\u30b8\u30a7\u30cd\u30c6\u30a3\u30c3\u30af\u7642\u6cd5\u3092\u958b\u767a\u3057\u3066\u3044\u307e\u3059\u3002\u7db2\u819c\u5909\u6027\u75be\u60a3\u306b\u5bfe\u3059\u308bRESTORE\u30d5\u30a7\u30fc\u30ba2b\u591a\u65bd\u8a2d\u30e9\u30f3\u30c0\u30e0\u5316\u4e8c\u91cd\u76f2\u691c\u507d\u5bfe\u7167\u81e8\u5e8a\u8a66\u9a13\u306e\u826f\u597d\u306a\u8a66\u9a13\u7d42\u4e86\u7d50\u679c\u3092\u53d7\u3051\u3066\uff08<a href=\"https:\/\/clinicaltrials.gov\/study\/NCT04945772\" target=\"_blank\" rel=\"nofollow noopener\">NCT04945772<\/a>\uff09\u3001\u540c\u793e\u306f\u3001\u00a0<a href=\"https:\/\/nanostherapeutics.com\/ja\/2024\/10\/10\/nanoscope-announces-plans-to-submit-bla-for-mco-010-to-treat-retinitis-pigmentosa\/\" target=\"_blank\" rel=\"nofollow noopener\">RP\u6cbb\u7642\u85acMCO-010\u306eBLA\u7533\u8acb<\/a>\u00a0\u540c\u793e\u306f\u3001\u30b9\u30bf\u30fc\u30ac\u30eb\u30c8\u75c5\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305fMCO-010\u7642\u6cd5\u306e\u7b2c2\u76f8STARLIGHT\u8a66\u9a13\u3092\u5b8c\u4e86\u3057\u305f\uff08<a href=\"https:\/\/clinicaltrials.gov\/study\/NCT05417126\" target=\"_blank\" rel=\"nofollow noopener\">NCT05417126<\/a>\uff09\u3092\u958b\u59cb\u3057\u3001\u00a0<a href=\"https:\/\/nanostherapeutics.com\/ja\/2024\/09\/12\/nanoscope-therapeutics-announces-end-of-phase-2-meeting-with-u-s-fda-and-plan-to-initiate-a-phase-3-clinical-trial-of-mco-010-to-treat-stargardt-macular-degeneration\/\" target=\"_blank\" rel=\"nofollow noopener\">\u30d5\u30a7\u30fc\u30ba3\u767b\u9332\u8a66\u9a13<\/a>\u00a02025\u5e74\u7b2c1\u56db\u534a\u671f\u306b\u767a\u58f2\u4e88\u5b9a\u3067\u3059\u3002MCO-010\u306f\u3001RP\u3068Stargardt\u306e\u4e21\u65b9\u3067FDA\u30d5\u30a1\u30b9\u30c8\u30c8\u30e9\u30c3\u30af\u6307\u5b9a\u3068FDA\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3092\u53d7\u3051\u3066\u3044\u307e\u3059\u3002\u524d\u81e8\u5e8a\u30d7\u30ed\u30b0\u30e9\u30e0\u306b\u306f\u3001IND\u5bfe\u5fdc\u306eGA\u5411\u3051\u975e\u30a6\u30a4\u30eb\u30b9\u6027\u30ec\u30fc\u30b6\u30fc\u9001\u9054MCO-020\u8cc7\u7523\u3068\u3001IND\u5bfe\u5fdc\u7814\u7a76\u4e2d\u306eLeber\u5148\u5929\u6027\u9ed2\u5185\u969c\u5411\u3051AAV\u8cc7\u7523\u304c\u542b\u307e\u308c\u307e\u3059\u3002<\/p>\n<p><b>\u6295\u8cc7\u5bb6\u9023\u7d61\u5148:<\/b><br class=\"dnr\" \/>\u30a2\u30eb\u30b4\u30c3\u30c8\u30d1\u30fc\u30c8\u30ca\u30fc\u30ba<br class=\"dnr\" \/>212-600-1902<br class=\"dnr\" \/><a href=\"mailto:PR@nanostherapeutics.com\" target=\"_blank\" rel=\"nofollow noopener\">PR@nanostherapeutics.com<\/a><\/p>\n<p>\u51fa\u5178 \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>DALLAS,\u00a0March 5, 2025 \u2014\u00a0Nanoscope Therapeutics Inc., a late-stage clinical biotechnology company developing gene therapies for inherited retinal diseases and age-related macular degeneration (AMD), today announced that\u00a0Ramesh Arjunji, PhD, has joined Nanoscope as Executive Vice President of Value and Access. Dr. Arjunji brings a breadth of experience including commercialization, R&#038;D, medical affairs and business development gained from various leadership positions in the biopharmaceutical industry. \u201cIn addition to his diverse industry experience spanning ophthalmology, neurology, oncology, immunology and medical devices, Ramesh has been an important market access leader for some of the most successfully commercialized gene therapies. We look forward to his contributions as we make preparations to launch MCO-010 as the [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":5967,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[13,8],"tags":[],"class_list":["post-5973","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-home-page","category-nanoscope-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pharma Executive and Gene Therapy Access Expert, Ramesh Arjunji, PhD, Joins Nanoscope as Executive Vice President, Value and Access - Nanoscope Therapeutics<\/title>\n<meta name=\"description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanostherapeutics.com\/ja\/2025\/03\/05\/pharma-executive-and-gene-therapy-access-expert-ramesh-arjunji-phd-joins-nanoscope-as-executive-vice-president-value-and-access\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma Executive and Gene Therapy Access Expert, Ramesh Arjunji, PhD, Joins Nanoscope as Executive Vice President, Value and Access - Nanoscope Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanostherapeutics.com\/ja\/2025\/03\/05\/pharma-executive-and-gene-therapy-access-expert-ramesh-arjunji-phd-joins-nanoscope-as-executive-vice-president-value-and-access\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanoscope Therapeutics\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-05T22:37:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-22T21:39:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_LI_RameshArjunji_V4.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Wilson PJ\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_LI_RameshArjunji_V4.jpg\" \/>\n<meta name=\"twitter:creator\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:site\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Wilson PJ\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"3\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/05\\\/pharma-executive-and-gene-therapy-access-expert-ramesh-arjunji-phd-joins-nanoscope-as-executive-vice-president-value-and-access\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/05\\\/pharma-executive-and-gene-therapy-access-expert-ramesh-arjunji-phd-joins-nanoscope-as-executive-vice-president-value-and-access\\\/\"},\"author\":{\"name\":\"Wilson PJ\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/2fa4c7d9fcf90c2c01f1341935baf02d\"},\"headline\":\"Pharma Executive and Gene Therapy Access Expert, Ramesh Arjunji, PhD, Joins Nanoscope as Executive Vice President, Value and Access\",\"datePublished\":\"2025-03-05T22:37:00+00:00\",\"dateModified\":\"2025-09-22T21:39:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/05\\\/pharma-executive-and-gene-therapy-access-expert-ramesh-arjunji-phd-joins-nanoscope-as-executive-vice-president-value-and-access\\\/\"},\"wordCount\":495,\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/05\\\/pharma-executive-and-gene-therapy-access-expert-ramesh-arjunji-phd-joins-nanoscope-as-executive-vice-president-value-and-access\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_LI_RameshArjunji_V4.jpg\",\"articleSection\":[\"Home Page\",\"Nanoscope Press Release\"],\"inLanguage\":\"ja\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/05\\\/pharma-executive-and-gene-therapy-access-expert-ramesh-arjunji-phd-joins-nanoscope-as-executive-vice-president-value-and-access\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/05\\\/pharma-executive-and-gene-therapy-access-expert-ramesh-arjunji-phd-joins-nanoscope-as-executive-vice-president-value-and-access\\\/\",\"name\":\"Pharma Executive and Gene Therapy Access Expert, Ramesh Arjunji, PhD, Joins Nanoscope as Executive Vice President, Value and Access - Nanoscope Therapeutics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/05\\\/pharma-executive-and-gene-therapy-access-expert-ramesh-arjunji-phd-joins-nanoscope-as-executive-vice-president-value-and-access\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/05\\\/pharma-executive-and-gene-therapy-access-expert-ramesh-arjunji-phd-joins-nanoscope-as-executive-vice-president-value-and-access\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_LI_RameshArjunji_V4.jpg\",\"datePublished\":\"2025-03-05T22:37:00+00:00\",\"dateModified\":\"2025-09-22T21:39:43+00:00\",\"description\":\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/05\\\/pharma-executive-and-gene-therapy-access-expert-ramesh-arjunji-phd-joins-nanoscope-as-executive-vice-president-value-and-access\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/05\\\/pharma-executive-and-gene-therapy-access-expert-ramesh-arjunji-phd-joins-nanoscope-as-executive-vice-president-value-and-access\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/05\\\/pharma-executive-and-gene-therapy-access-expert-ramesh-arjunji-phd-joins-nanoscope-as-executive-vice-president-value-and-access\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_LI_RameshArjunji_V4.jpg\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_LI_RameshArjunji_V4.jpg\",\"width\":1200,\"height\":800},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/05\\\/pharma-executive-and-gene-therapy-access-expert-ramesh-arjunji-phd-joins-nanoscope-as-executive-vice-president-value-and-access\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nanostherapeutics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma Executive and Gene Therapy Access Expert, Ramesh Arjunji, PhD, Joins Nanoscope as Executive Vice President, Value and Access\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"name\":\"Nanoscope Therapeutics\",\"description\":\"Bringing Back the Light of Hope\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"alternateName\":\"Nanoscope Therapeutics\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanostherapeutics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\",\"name\":\"Nanoscope Therapeutics, Inc\",\"alternateName\":\"Nanoscope Therapeutics\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"width\":512,\"height\":435,\"caption\":\"Nanoscope Therapeutics, Inc\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/NSTherapeutics\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/nanoscope\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/2fa4c7d9fcf90c2c01f1341935baf02d\",\"name\":\"Wilson PJ\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u88fd\u85ac\u696d\u754c\u306e\u30a8\u30b0\u30bc\u30af\u30c6\u30a3\u30d6\u3067\u3042\u308a\u3001\u907a\u4f1d\u5b50\u6cbb\u7642\u30a2\u30af\u30bb\u30b9\u5c02\u9580\u5bb6\u3067\u3082\u3042\u308b\u30e9\u30e1\u30b7\u30e5\u30fb\u30a2\u30eb\u30b8\u30e5\u30f3\u30b8\u535a\u58eb\u304c\u3001\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u793e\u306b\u30d0\u30ea\u30e5\u30fc\uff06\u30a2\u30af\u30bb\u30b9\u62c5\u5f53\u30a8\u30b0\u30bc\u30af\u30c6\u30a3\u30d6\u30d0\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u3068\u3057\u3066\u5165\u793e - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanostherapeutics.com\/ja\/2025\/03\/05\/pharma-executive-and-gene-therapy-access-expert-ramesh-arjunji-phd-joins-nanoscope-as-executive-vice-president-value-and-access\/","og_locale":"ja_JP","og_type":"article","og_title":"Pharma Executive and Gene Therapy Access Expert, Ramesh Arjunji, PhD, Joins Nanoscope as Executive Vice President, Value and Access - Nanoscope Therapeutics","og_description":"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.","og_url":"https:\/\/nanostherapeutics.com\/ja\/2025\/03\/05\/pharma-executive-and-gene-therapy-access-expert-ramesh-arjunji-phd-joins-nanoscope-as-executive-vice-president-value-and-access\/","og_site_name":"Nanoscope Therapeutics","article_published_time":"2025-03-05T22:37:00+00:00","article_modified_time":"2025-09-22T21:39:43+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_LI_RameshArjunji_V4.jpg","type":"image\/jpeg"}],"author":"Wilson PJ","twitter_card":"summary_large_image","twitter_image":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_LI_RameshArjunji_V4.jpg","twitter_creator":"@NSTherapeutics","twitter_site":"@NSTherapeutics","twitter_misc":{"\u57f7\u7b46\u8005":"Wilson PJ","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"3\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nanostherapeutics.com\/2025\/03\/05\/pharma-executive-and-gene-therapy-access-expert-ramesh-arjunji-phd-joins-nanoscope-as-executive-vice-president-value-and-access\/#article","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/2025\/03\/05\/pharma-executive-and-gene-therapy-access-expert-ramesh-arjunji-phd-joins-nanoscope-as-executive-vice-president-value-and-access\/"},"author":{"name":"Wilson PJ","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/2fa4c7d9fcf90c2c01f1341935baf02d"},"headline":"Pharma Executive and Gene Therapy Access Expert, Ramesh Arjunji, PhD, Joins Nanoscope as Executive Vice President, Value and Access","datePublished":"2025-03-05T22:37:00+00:00","dateModified":"2025-09-22T21:39:43+00:00","mainEntityOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2025\/03\/05\/pharma-executive-and-gene-therapy-access-expert-ramesh-arjunji-phd-joins-nanoscope-as-executive-vice-president-value-and-access\/"},"wordCount":495,"publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2025\/03\/05\/pharma-executive-and-gene-therapy-access-expert-ramesh-arjunji-phd-joins-nanoscope-as-executive-vice-president-value-and-access\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_LI_RameshArjunji_V4.jpg","articleSection":["Home Page","Nanoscope Press Release"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/nanostherapeutics.com\/2025\/03\/05\/pharma-executive-and-gene-therapy-access-expert-ramesh-arjunji-phd-joins-nanoscope-as-executive-vice-president-value-and-access\/","url":"https:\/\/nanostherapeutics.com\/2025\/03\/05\/pharma-executive-and-gene-therapy-access-expert-ramesh-arjunji-phd-joins-nanoscope-as-executive-vice-president-value-and-access\/","name":"\u88fd\u85ac\u696d\u754c\u306e\u30a8\u30b0\u30bc\u30af\u30c6\u30a3\u30d6\u3067\u3042\u308a\u3001\u907a\u4f1d\u5b50\u6cbb\u7642\u30a2\u30af\u30bb\u30b9\u5c02\u9580\u5bb6\u3067\u3082\u3042\u308b\u30e9\u30e1\u30b7\u30e5\u30fb\u30a2\u30eb\u30b8\u30e5\u30f3\u30b8\u535a\u58eb\u304c\u3001\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u793e\u306b\u30d0\u30ea\u30e5\u30fc\uff06\u30a2\u30af\u30bb\u30b9\u62c5\u5f53\u30a8\u30b0\u30bc\u30af\u30c6\u30a3\u30d6\u30d0\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u3068\u3057\u3066\u5165\u793e - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2025\/03\/05\/pharma-executive-and-gene-therapy-access-expert-ramesh-arjunji-phd-joins-nanoscope-as-executive-vice-president-value-and-access\/#primaryimage"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2025\/03\/05\/pharma-executive-and-gene-therapy-access-expert-ramesh-arjunji-phd-joins-nanoscope-as-executive-vice-president-value-and-access\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_LI_RameshArjunji_V4.jpg","datePublished":"2025-03-05T22:37:00+00:00","dateModified":"2025-09-22T21:39:43+00:00","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","breadcrumb":{"@id":"https:\/\/nanostherapeutics.com\/2025\/03\/05\/pharma-executive-and-gene-therapy-access-expert-ramesh-arjunji-phd-joins-nanoscope-as-executive-vice-president-value-and-access\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanostherapeutics.com\/2025\/03\/05\/pharma-executive-and-gene-therapy-access-expert-ramesh-arjunji-phd-joins-nanoscope-as-executive-vice-president-value-and-access\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/2025\/03\/05\/pharma-executive-and-gene-therapy-access-expert-ramesh-arjunji-phd-joins-nanoscope-as-executive-vice-president-value-and-access\/#primaryimage","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_LI_RameshArjunji_V4.jpg","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_LI_RameshArjunji_V4.jpg","width":1200,"height":800},{"@type":"BreadcrumbList","@id":"https:\/\/nanostherapeutics.com\/2025\/03\/05\/pharma-executive-and-gene-therapy-access-expert-ramesh-arjunji-phd-joins-nanoscope-as-executive-vice-president-value-and-access\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nanostherapeutics.com\/"},{"@type":"ListItem","position":2,"name":"Pharma Executive and Gene Therapy Access Expert, Ramesh Arjunji, PhD, Joins Nanoscope as Executive Vice President, Value and Access"}]},{"@type":"WebSite","@id":"https:\/\/nanostherapeutics.com\/#website","url":"https:\/\/nanostherapeutics.com\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5e0c\u671b\u306e\u5149\u3092\u53d6\u308a\u623b\u3059","publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"alternateName":"Nanoscope Therapeutics","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanostherapeutics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/nanostherapeutics.com\/#organization","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e","alternateName":"Nanoscope Therapeutics","url":"https:\/\/nanostherapeutics.com\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","width":512,"height":435,"caption":"Nanoscope Therapeutics, Inc"},"image":{"@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/NSTherapeutics","https:\/\/www.linkedin.com\/company\/nanoscope"]},{"@type":"Person","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/2fa4c7d9fcf90c2c01f1341935baf02d","name":"\u30a6\u30a3\u30eb\u30bd\u30f3 PJ"}]}},"_links":{"self":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5973","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/comments?post=5973"}],"version-history":[{"count":2,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5973\/revisions"}],"predecessor-version":[{"id":9650,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5973\/revisions\/9650"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media\/5967"}],"wp:attachment":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media?parent=5973"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/categories?post=5973"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/tags?post=5973"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}